ViiV Healthcare, today announced the positive findings of a pooled analysis of COVID-19-related impacts across the investigational long-acting cabotegravir and rilpivirine clinical ... Oct 21
GSK two drug combination is as good as 3 drug regimen which is presently continued for HIV 1 patients... Oct 09
-Advertisements-